Background: Acute intermittent porphyria (AIP) is a rare hepatic porphyria that may progress to severe neurovisceral complications if unrecognized. Its early clinical features often mimic common gastrointestinal (GI) disorders, resulting in frequent misdiagnoses and delayed treat [....]
» Read More
Krivitskaya Mariia Valeryevna, R.M. Gorbacheva Memorial Research Institute of Pediatric Oncology, Russian Federation
Myelodysplastic Syndrome (MDS) represents a heterogeneous group of clonal hematopoietic disorders. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only potentially curative therapy, yet factors influencing post-transplant outcomes remain insufficiently under [....]
» Read More
Title : Acute intermittent porphyria: A neurological dilemma obscured by ubiquitous fgastrointestinal presentation
Mayank Anand Singh, Mimer Medical College, India
Background: Acute intermittent porphyria (AIP) is a rare hepatic porphyria that may progress to severe neurovisceral complications if unrecognized. Its early clinical features often mimic common gastrointestinal (GI) disorders, resulting in frequent misdiagnoses and delayed treat [....] » Read More
Title : Allogeneic transplant outcomes in patients with myelodysplastic neoplasms
Krivitskaya Mariia Valeryevna, R.M. Gorbacheva Memorial Research Institute of Pediatric Oncology, Russian Federation
Myelodysplastic Syndrome (MDS) represents a heterogeneous group of clonal hematopoietic disorders. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only potentially curative therapy, yet factors influencing post-transplant outcomes remain insufficiently under [....] » Read More